Skip to Content

This page is intended for US Healthcare Providers and residents only.

- EUA Fact Sheet and full PI for Vaccination Providers,
  Primary Series + Booster
- EUA Fact Sheet and full PI for Vaccination Providers,
  Booster Dose Only Presentation
EUA Fact Sheet and full PI for Vaccination Providers,
Primary Series + Booster
EUA Fact Sheet and full PI for Vaccination Providers,
Booster Dose Only Presentation
EUA Fact Sheet for
Vaccine Recipients
FDA EUA Letter
Visit spikevax
(COVID-19 vaccine, mRNA)

Moderna COVID-19 Vaccine

Sitemap

Home

Vaccine Recipients

Home
What is the Moderna COVID-19 Vaccine
Safety
Who Can Get Vaccinated
FAQs
Multi-Language Resources

Vaccination Providers

Home
About Our Vaccine
Storage & Handling
Dosing & Administration
Clinical Trial Data
Resources
FAQs
How To Look Up Vial Expiration Date
Multi-Language Resources

About Moderna

www.ModernaTX.com

1‑866‑MODERNA (1‑866‑663‑3762)
8:00AM - 8:00PM EST, Monday-Friday (not including Holidays)

© 2021 Moderna, Inc. US-COV-2200044 04/2022
Privacy Policy
Terms of Use
Sitemap

You are about to leave this website

You are now leaving www.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.

For Vaccination Providers Only

This website contains information intended for vaccination providers in the United States only and is not intended for the general public.

Yes, I'm a vaccination provider

Label Update Effective March 2022

The Emergency Use Authorization (EUA) Fact Sheets for Vaccination Providers have updates related to vial presentation and dosing. See below for details.

For certain indications, the Moderna COVID‑19 Vaccine has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by the FDA, under an Emergency Use Authorization (EUA), to prevent Coronavirus Disease 2019 (COVID‑19) in individuals 18 years of age and older. There are two presentations/formulations of the Moderna COVID‑19 Vaccine authorized for use.
The EUA for the Moderna COVID‑19 Vaccine is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.
See below for Moderna COVID‑19 Vaccine Authorized Uses

EUA Fact Sheet and full PI for Vaccination Providers, Primary Series + Booster

EUA Fact Sheet and full PI for Vaccination Providers, Booster Dose Only Presentation

Moderna COVID-19 Vaccine Presentations

Authorized Uses

Moderna COVID‑19 Vaccine is authorized to provide:

a two-dose primary series to individuals 18 years of age and older;
a third primary series dose to individuals 18 years of age and older with certain kinds of immunocompromise;
a first booster dose to individuals 18 years of age and older who have completed a primary series with Moderna COVID‑19 Vaccine or SPIKEVAX (COVID‑19 Vaccine, mRNA);
a first booster dose to individuals 18 years of age and older who have completed primary vaccination with another authorized or approved COVID‑19 vaccine. The dosing interval for the heterologous booster dose is the same as that authorized for a booster dose of the vaccine used for primary vaccination;
a second booster dose to individuals 50 years of age and older who have received a first booster dose of any authorized or approved COVID‑19 vaccine; and
a second booster dose to individuals 18 years of age and older with certain kinds of immunocompromise and who have received a first booster dose of any authorized or approved COVID‑19 vaccine.

FDA has approved SPIKEVAX (COVID‑19 Vaccine, mRNA) as a two-dose primary series one month apart for prevention of COVID‑19 in individuals ages 18 years of age and older.